Dr. Lambertson joined the OTT in 2005. Prior to joining the NIH, Dr. Lambertson was a patent examiner with the US Patent and Trademark Office. Dr. Lambertson received his Ph.D. in Biochemistry and Molecular Biology from The University of Medicine and Dentistry of New Jersey, and his BS in Biochemistry from Rutgers University, where he was a George H. Cook Scholar.

Jaime is a USPTO alum where she worked in Art Unit 1634 evaluating nucleic acid hybridization-related patent applications. Prior to working at the PTO, she worked at a small systems biology startup company in Cambridge, MA. Jaime obtained her master’s degree from the University of Heidelberg in Heidelberg, Germany and her bachelor’s degree from the George Washington University in Washington, DC.

Dr. Chatterjee was a Licensing and Patenting Associate at OTT before joining the Cancer Branch as a Licensing and Patenting Manager. Prior to that Dr. Chatterjee he has worked as a Technical Specialist in the Biotechnology/Chemical Group at a Washington D.C. IP law firm and a Senior Technology Transfer Fellow at OTT. Dr. Chatterjee is a co-founder of a start-up company that provides information technology and statistical solutions for the healthcare industry.

Dr. Chang joined OTT in May 2008. Prior to joining OTT, he was a technology transfer specialist fellow at the National Cancer Institute (NCI) Technology Transfer Center assisting NCI scientists with agreements for the transfer of materials and collaborations with public and private entities. This followed several years as a postdoctoral fellow at NCI Frederick where he studied and published several papers on retroviral vectors and replication. Dr. Chang received his Ph.D.